What’s Happening in Cannabis: Q3

November 2021

This latest in our series of quarterly briefings discusses the main news affecting the global cannabis industry during July-October 2021. It covers the key regulation announcements, the corporate activity among companies involved in the production or the distribution of products containing cannabinoids, alongside major product innovations in the industry. It also looks at global macro-economic trends and what are some of the likely changes set to shape the industry in the following quarter.

USD 1,325
Request More Information

Key Findings

The latest Euromonitor International macroeconomic forecasts

The global economic outlook for 2021 has worsened moderately since mid-2021, offset by slightly more optimistic recovery forecasts for 2022. Global real GDP is now forecast to increase by 5.7% in 2021 (a 0.2 percentage point downgrade since July 2021), and by 4.8% in 2022 (a 0.2 percentage point improvement relative to the July 2021 forecast). Since July 2021, real GDP growth forecasts for 2021 have been significantly downgraded for the US, Canada, China, India, and other Asia Pacific economies, such as Indonesia and Australia. By contrast, 2021 forecasts have improved substantially for the Eurozone, Eastern Europe and Latin America.

The growth in global economic activity in Q3 2021 was stronger than expected. However, the spread of the much more infectious Delta COVID-19 variant and worsening supply constraints have tempered global economic recovery. The global economy is facing various supply bottlenecks, including a lack of shipping containers, truck drivers, computer chips, electricity shortages in China and India, and rising commodity prices. Together with a rapid increase in global demand, these factors have led to occasional shortages, elevated production costs and filtered into higher price inflation in many economies.

North America: regulatory updates
Latin America: regulatory updates
Europe: regulatory updates
Asia Pacific: regulatory updates
Rest of the world: regulatory updates
Prevalence updates: Europe
Market and product updates (1)
Market and product updates (2)
New product developments and innovations (1)
New product developments and innovations (2)
New product developments and innovations (3)
Flora Growth acquires Koch & Gsell and creates the division Flora Pharma
Canopy Growth and Sundial Growers expand through major acquisitions
The latest Euromonitor macroeconomic forecasts
Forecast risks remain tilted to the downside
Real GDP annual growth forecasts and revisions from last quarter, AE
Real GDP annual growth forecasts and revisions from last quarter, EMDE
What to expect Q4 (1)
What to expect Q4 (2)


If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE! Home Page